Review Article
Cardiac Troponin Mutations and Restrictive Cardiomyopathy
Table 1
Clinical data were collected from in vivo and/or ex vivo human and transgenic mice hearts containing the RCM-associated mutation. The diagnosis of RCM was given on the basis of echocardiographic, electrocardiographic, and/or cardiac catheterization examination. The maximal wall thickness (MWT) was measured from the septal or free wall (or both). In vitro data were collected from skinned cardiac muscle preparations reconstituted with the mutant or expressed as a transgene product. The maximal force and ATPase generating capabilities (max force/ATPase) were tested in high [Ca2+]; whereas the ability of the muscle to relax or inhibit the ATPase activity (relax/inhibit) was measured in low [Ca2+]. ∆pCa50, –log at which 50% of the maximal response occurs (– or + denotes an increase or decrease in the Ca2+ sensitivity, resp.). BA: both atria; DP: diastolic pressure; E/A: ratio of early diastolic filling [E] to atrial filling [A]; EF: ejection fraction; IF: impaired filling; IRT: intraventricular or isovolumic relaxation time; LV: left ventricle; LVOTO: LV outflow tract obstruction; SCD: sudden cardiac death; ND: not determined.
|